Slots/Windows of Opportunities HTA – Medical Devices Dr. Wolfgang Ecker EUnetHTA, Rome, 30. 10. 2014.

Slides:

Advertisements

Similar presentations

And the provisions of….. the Medical Devices Regulations Medical Devices Agency.

Advertisements

Medical Devices Regulation in the European Union Albuquerque - 10 April 2012 Emmanuel Grimaud Perfea Innovation Lyon, France – Albuquerque, NM

Prof. A. De Wever SAFETY, EFFICACY, QUALITY AND RISK/BENFIT RATIO Source : Marc Czarka.

Current EU and Global Activities in the „Clinicals“ Dr. Wolfgang Ecker Federal Ministry of Health, Austria Chairman of EU WG CIE 3rd National Conference.

Croatian Government’s Priorities in the Regulatory Area UNECE-SIDA “South East Europe Regulatory Project” Ljubljana, 8 June 2004.

© Safeguarding public health Implementing Medical Device Regulation and Maintaining Patient Safety Name Nicola Lennard Date October 2011.

Implementation - Medical Devices. Overview Act on Medical Devices – background and overview. Surveillance - Competent authority. Directive 93/42. Directive.

I&EHL: EU Pharmaceutical Law André den Exter

CE marking Catriona Blake Team Manager, Imaging, acute and community care.

Medical Device Revisions Case Study Phil Brown 20th September 2012.

EMERGING AND RE-EMERGING INFECTIOUS DISEASES: A CONTINUOUS CHALLENGE FOR EUROPE STOA - AVIESAN Workshop June 19th 2012, European Parliament, Bruxelles.

Overview of Medical Devices Sector Saudi Food and Drug Authority (Saudi Arabia) Dr. Saleh Al Tayyar Director General Medical Devices Sector Saudi Food.

Regulatory Update Ellen Leinfuss SVP, Life Sciences.

NATIONAL AGENCY FOR VOCATIONAL EDUCATION AND TRAINING, BULGARIA The 4th meeting of the SEEVET-Net July, 2011 Chisinau, Moldova.

Revision of the Medical Device Directives The case of ‘Borderline’ Products used in a self-care context 48th AESGP Annual Meeting Nice, 6-8 June 2012 Laurent.

GLOBAL HARMONIZATION TASK FORCE (GHTF) UPDATE: PLANNING THE 2012 ACTIVITIES Laurent Sellès DHoU SANCO B2 “Cosmetics and Medical Devices” CAMD.

The concept for a network of national Reference Laboratories for high risk IVDs – Results of the working group meeting 1.

Report on WG Clinical Investigation and Evaluation (CIE) Wolfgang Ecker Fed. Min. of Health, Austria Chairman CIE Cracow,

HTA cooperation in the EU EPF workshop Jérôme Boehm 18 May 2010.

The revised EU Cosmetics Legislation

28th Meeting of the Competent Authorities Matthias Neumann Federal Ministry of Health, Germany Cracow, 27th of October 2011 Central Management Committee:

1 Harmonisation within a merger of two spot power exchanges - Experiences by EEX and Powernext APEX CONFERENCE 2008 IN SYDNEY | 13 October 2008 Dr. Wolfgang.

SANCO-D-4 International Questions (bilateral) General Food Law of the EU – Amman, 29 November 2010 Wolf Maier, DG Health and Consumers, EU Commission.

EU cooperation on HTA – the way forward Andrzej Rys Director European Commission DG Health and Consumers Health Systems and Products HTA 2.0 Europe - Teaming.

1 st Workshop on issues and trends arising from the European IRRS missions Findings and Conclusions A.Munuera Brussels, 22 nd and 23 rd January 2014.

Croatian Government’s Priorities in the Regulatory Area UNECE Round Table on Regulatory Cooperation in South East Europe Geneva, 22 November 2004.

Directorate General for Enterprise and Industry European Commission The New Legislative Framework - Market Surveillance UNECE “MARS” Group meeting Bratislava,

Proposal for a Regulation of the European Parliament and of the Council on medical devices and amending Directive 2001/83/EC, Regulation (EC) No 178/2002.

UPCOMING CHANGES TO IN-VITRO DIAGNOSTICS (IVDs) AND LABORATORY DEVELOPED TESTS (LDTs) REGULATIONS Moj Eram, PhD November 5, 2015.

GLOBAL HARMONIZATION TASK FORCE (GHTF) UPDATE: PLANNING THE 2012 ACTIVITIES Laurent Sellès DHoU SANCO B2 “Cosmetics and Medical Devices” CAMD.

Research in the Office of Cellular, Tissue and Gene Therapies: Vision and Overview Jesse Goodman, M.D., M.P.H. Director, Center for Biologics Evaluation.

SEVESO II transposition and implementation: Possible approaches and lessons learned from member states and new member states SEVESO II transposition and.

WORKSHOP ON ACCREDITATION OF BODIES CERTIFYING MEDICAL DEVICES INT MARKET TOPIC 9 CH 8 ISO MEASUREMENT, ANALYSIS AND IMPROVEMENT INTERNAL AUDITS.

China EU Pharmaceutical Forum

CLAUDIA PANAIT TAIEX Expert – European Commission Legal Adviser Ministry of Health, ROMANIA.

European Diagnostic Manufacturers Association EQA contribution and industry expectations Dr. Claude GIROUD – Chairman Standardization, Quality & Risk Management.

THE OFFICE FOR REGISTRATION OF MEDICINAL PRODUCTS, MEDICAL DEVICES AND BIOCIDAL PRODUCTS Responsibility in the handling of medical devices.

Slide 1 The contribution of a world-class regulatory environment to the future of the industry in Ireland Pat O’Mahony Chief Executive, Irish Medicines.

Device regulations USA Dr Phil Warner. USA Regulations MEDICAL DEVICES Food, Drug & Cosmetics Act Medical Device Amendments of 1976 (and other things)

Workshop on conformity assessment procedures and certification of medical devices INT MARKT Kyiv, November 2011 Conformity assessment of medical.

Responsibilities of Sponsor, Investigator and Monitor

Health and Consumers Health and Consumers Introduction to the new Medical Device Regulations and their impact on medical software DG for Internal Market,

Clusters working group COM/CAMD New Regulations

Update on EU regulatory developments

Industry Implementation Priorities & Challenges COM/CAMD Stakeholders meeting on the new MD and IVD Regulations 9 March, 2017 John Brennan Director.

Flowchart on overview of requirements

Medicine Pricing Policy in China

Australian Jurisdictional Update March 2017

Responsibilities of Sponsor, Investigator and Monitor

Growing need of Clinical Data, PMCF & Registries for Devices Post Market Clinical Follow Up (PMCF) studies are a critical component of the clinical evidence.

Nicole Denjoy COCIR Secretary General

Evaluation and use of coronary bioresorbable scaffolds:

The Current PMA Requirements

REGULATORY PROBLEMS IN CARING OUT PRE- AND POST- AUTHORISATION CLINICAL TRIALS Dr Penka Decheva GCP Inspector, BDA.

MakroCare is organizing the webinar on Device Registries as PMCF tools. This webinar will provide an overview of PMCF requirements, outline elements of a well-designed registry and offer advice about known, potential pitfalls.

Medical Device PMS & PMCF: Challenges & Opportunities The new 2017/745/EU Medical Device Regulations (MDR-2020) require increased emphasis on Post- Market.

New European Medical Device Regulations – major changes that will affect all devices Rene van de Zande EMERGO | President & CEO

FOOD AND VETERINARY OFFICE

03/12/2018 Update - EU Medical Device Regulation Utah Life Science Summit November 2015 Paul Brooks Senior Vice President Healthcare Solutions.

Quality and Regulatory Planning – the way forward?

Drug-device combinations regulated as medicines - Revised regulatory

NEW MDR Regulatory Context. NEW MDR Regulatory Context.

Evidence standards for device approval: Regulatory perspectives

MEDICAL DEVICES CONTROL SYSTEM IN INDONESIA

The European Association Medical devices

The European Association Medical devices

APPLICATIONS Sent to SANTE/F: 38 – MDR 9 – IVDR 47

An introduction to EMA’s support for medicines development

EUnetHTA Assembly May 2018.

Future Developments Update MoU between ENSREG and IAEA considering the Waste Directive EC working to establishing a new financial contribution agreement.

Presentation transcript:

Slots/Windows of Opportunities HTA – Medical Devices Dr. Wolfgang Ecker EUnetHTA, Rome,

Directive 90/385/EEC Active Implantable Medical Devices Directive 93/42/EEC Medical Devices Directive 98/79/EC In-vitro-Diagnostic- Medical Devices Regulation Medical Devices Regulation In-vitro-Diagnostic- Medical Devices 3 D IRECTIVES : > T RANSPOSITION INTO NATIONAL LAW 2 Regulations: > directly applicable EU-legislation

Considerable improvement in Clinicals expected:  Notified Bodies – better clinical qualification  Notified Bodies under better EU-scrutiny  Scrutiny procedure (pre-/post-market?)  Clinical Evaluation (MD) – Life cycle process  Performance Evaluation (IVD) – better defined process  Scientific infrastructure: Device/expert Panels; RefLabs  Long term: Registries, PMCF, PMPF  Better clinical transparency But: Still weakness in terminology! (Efficacy? Effectiveness?) MD - Progress on Clinicals EUnetHTA, Rome, MD-HTA-Slots

HTA – MD Interaction: Governance Device/Expert Panels MS Competent and Designating Authorities MD Coordinating Comittee (MDCG) Joint Assessment Team (JAT) (EU Reference Labs for IVDs?) Device Registry evaluations HTA to serve as experts for Expert/Device Panels and/or for MS, MDCG, JAT:

Clinical Evaluation Plan + Report Scrutiny Discussion: pre-/post market? Notified Body Manufacturer MDCG? COM? Clinical Evaluation Assessment Report EUnetHTA, Rome, MD-HTA-Slots Notified Body MDCG? COM? Clinical AUDIT PMCF; Updates of Clinical Evaluation; Recertification Device/Expert Panels + EU RefLabs Clinical AUDIT HTA in agreement with MF/NB or as experts for DP or MS/JAT MS-DA JAT Expert Panel? MS-DA JAT Expert Panel? Pre-Post-market

HTA – MD Interaction: Guidance Common Specifications (CS): –Clinical Investigations –Clinical Evaluation –Post Market Follow-up (PMCF) Summary of Safety and Clinical Performance Data (SSPD) Templates Harmonised Standards? HTA as part of Expert/Device Panels could contribute to Guidance for specific device types:

HTA – MD Interaction: Training Literature reviews Grading quality of clinical investigations Current state of the art in medicine (HTA, EBM) HTA to cooperate on web-based training for MD-stakeholders

Thank You!